Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of leukocyte chemotaxis (GO:0002689) | 5.20478661 |
2 | membrane raft organization (GO:0031579) | 4.89234514 |
3 | peptidyl-proline hydroxylation (GO:0019511) | 4.68528332 |
4 | response to nitrosative stress (GO:0051409) | 4.42347901 |
5 | protein hydroxylation (GO:0018126) | 4.16621229 |
6 | xenobiotic catabolic process (GO:0042178) | 4.08284445 |
7 | proteasome assembly (GO:0043248) | 4.06624061 |
8 | protein heterotrimerization (GO:0070208) | 3.95430514 |
9 | regulation of macrophage chemotaxis (GO:0010758) | 3.90305720 |
10 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.88814345 |
11 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.80953497 |
12 | response to redox state (GO:0051775) | 3.78299602 |
13 | triglyceride catabolic process (GO:0019433) | 3.68182932 |
14 | kidney mesenchyme development (GO:0072074) | 3.68130537 |
15 | cellular response to vitamin (GO:0071295) | 3.67122500 |
16 | collagen fibril organization (GO:0030199) | 3.66379886 |
17 | low-density lipoprotein particle clearance (GO:0034383) | 3.60647161 |
18 | cell migration involved in heart development (GO:0060973) | 3.58609872 |
19 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.53315515 |
20 | extracellular fibril organization (GO:0043206) | 3.50210765 |
21 | protein localization to cell surface (GO:0034394) | 3.45831033 |
22 | endodermal cell differentiation (GO:0035987) | 3.42499610 |
23 | metanephric mesenchyme development (GO:0072075) | 3.40962765 |
24 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.39324762 |
25 | blood vessel maturation (GO:0001955) | 3.38945217 |
26 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.23921786 |
27 | regulation of extracellular matrix disassembly (GO:0010715) | 3.23292016 |
28 | regulation of metalloenzyme activity (GO:0048552) | 3.23225138 |
29 | protein retention in ER lumen (GO:0006621) | 3.21196862 |
30 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.16414030 |
31 | keratan sulfate catabolic process (GO:0042340) | 3.16314653 |
32 | lipid particle organization (GO:0034389) | 3.16199038 |
33 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.08373209 |
34 | neutral lipid catabolic process (GO:0046461) | 3.07236887 |
35 | acylglycerol catabolic process (GO:0046464) | 3.07236887 |
36 | positive regulation of cell junction assembly (GO:1901890) | 3.06048385 |
37 | positive regulation of focal adhesion assembly (GO:0051894) | 3.06048385 |
38 | negative regulation of metanephros development (GO:0072217) | 3.05301000 |
39 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.05299087 |
40 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.03548715 |
41 | retinol metabolic process (GO:0042572) | 3.01324392 |
42 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.99380105 |
43 | positive regulation of osteoblast proliferation (GO:0033690) | 2.99337401 |
44 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.97370867 |
45 | type B pancreatic cell proliferation (GO:0044342) | 2.95452424 |
46 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.93502999 |
47 | retinal metabolic process (GO:0042574) | 2.92260438 |
48 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.88961431 |
49 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.87618682 |
50 | response to hyperoxia (GO:0055093) | 2.86265899 |
51 | response to increased oxygen levels (GO:0036296) | 2.86265899 |
52 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.84039526 |
53 | fatty acid elongation (GO:0030497) | 2.84017158 |
54 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.83101971 |
55 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043) | 2.82182791 |
56 | metanephric tubule development (GO:0072170) | 2.80623592 |
57 | metanephric nephron tubule development (GO:0072234) | 2.80623592 |
58 | hyaluronan catabolic process (GO:0030214) | 2.79382858 |
59 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.79351092 |
60 | positive regulation of adherens junction organization (GO:1903393) | 2.77448675 |
61 | regulation of sequestering of triglyceride (GO:0010889) | 2.75081342 |
62 | fatty acid homeostasis (GO:0055089) | 2.74159842 |
63 | fibril organization (GO:0097435) | 2.71536807 |
64 | negative regulation of BMP signaling pathway (GO:0030514) | 2.71457164 |
65 | metanephric nephron epithelium development (GO:0072243) | 2.71327156 |
66 | smooth muscle tissue development (GO:0048745) | 2.70912671 |
67 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.70872619 |
68 | endocrine hormone secretion (GO:0060986) | 2.69708104 |
69 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.69428555 |
70 | positive regulation of extracellular matrix organization (GO:1903055) | 2.67272293 |
71 | positive regulation of fibroblast migration (GO:0010763) | 2.65392093 |
72 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.65271665 |
73 | cellular response to vitamin D (GO:0071305) | 2.65189901 |
74 | membrane assembly (GO:0071709) | 2.63904495 |
75 | protein heterotetramerization (GO:0051290) | 2.60942291 |
76 | endothelial cell proliferation (GO:0001935) | 2.60144438 |
77 | substrate-dependent cell migration (GO:0006929) | 2.59022597 |
78 | artery development (GO:0060840) | 2.57806609 |
79 | membrane budding (GO:0006900) | 2.56894451 |
80 | metanephric epithelium development (GO:0072207) | 2.56121160 |
81 | negative regulation of cartilage development (GO:0061037) | 2.55116047 |
82 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.52108721 |
83 | endothelial cell morphogenesis (GO:0001886) | 2.51649386 |
84 | cellular response to zinc ion (GO:0071294) | 2.51364888 |
85 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.50443075 |
86 | extracellular matrix assembly (GO:0085029) | 2.47882316 |
87 | protein maturation by protein folding (GO:0022417) | 2.47315136 |
88 | primary alcohol metabolic process (GO:0034308) | 2.47065900 |
89 | endocardial cushion development (GO:0003197) | 2.43556608 |
90 | 4-hydroxyproline metabolic process (GO:0019471) | 2.43283470 |
91 | erythrocyte maturation (GO:0043249) | 2.43182840 |
92 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.41688421 |
93 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.40727835 |
94 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.40406526 |
95 | muscle cell migration (GO:0014812) | 2.35400916 |
96 | chondrocyte proliferation (GO:0035988) | 2.33768904 |
97 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.33376320 |
98 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.31102370 |
99 | white fat cell differentiation (GO:0050872) | 2.30488427 |
100 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.30455845 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 6.82751968 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.59193502 |
3 | CJUN_26792858_Chip-Seq_BT549_Human | 3.32481956 |
4 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.22446124 |
5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.15858731 |
6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.09902958 |
7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.07085008 |
8 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.89824902 |
9 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.87811689 |
10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.80485633 |
11 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.75114261 |
12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.63697999 |
13 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.56644408 |
14 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.49676365 |
15 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.35412740 |
16 | TP53_18474530_ChIP-ChIP_U2OS_Human | 2.23333406 |
17 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.18552227 |
18 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.17470326 |
19 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.17470326 |
20 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.14424045 |
21 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.11507447 |
22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.07173697 |
23 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.95831630 |
24 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.95831630 |
25 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.95466482 |
26 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.95263171 |
27 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.92172210 |
28 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.88707101 |
29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.84432018 |
30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.83579812 |
31 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.82440995 |
32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.82318250 |
33 | TP53_16413492_ChIP-PET_HCT116_Human | 1.79612656 |
34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.70138783 |
35 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.68878104 |
36 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.61360082 |
37 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55783847 |
38 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.53625194 |
39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.47585285 |
40 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.47434477 |
41 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.46981444 |
42 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.43568813 |
43 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.43216538 |
44 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.35707004 |
45 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.34463334 |
46 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.26270187 |
47 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.24481001 |
48 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24385208 |
49 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.24252869 |
50 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.23287085 |
51 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18461100 |
52 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.17320309 |
53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.17238233 |
54 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.16287325 |
55 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.15325762 |
56 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.14303116 |
57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13541465 |
58 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.12835041 |
59 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12451014 |
60 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.09834250 |
61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08154410 |
62 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.08030878 |
63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.07831541 |
64 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.06267175 |
65 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.06098130 |
66 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05776160 |
67 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.05756465 |
68 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05103180 |
69 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.04330255 |
70 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.04163906 |
71 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.04163906 |
72 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03723826 |
73 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.01153647 |
74 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.00751309 |
75 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00735634 |
76 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.00223519 |
77 | P300_19829295_ChIP-Seq_ESCs_Human | 0.99514134 |
78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.99449632 |
79 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98768602 |
80 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98290202 |
81 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.98018454 |
82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97680282 |
83 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.97342288 |
84 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.94070120 |
85 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90220585 |
86 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.89977833 |
87 | JUN_21703547_ChIP-Seq_K562_Human | 0.88721002 |
88 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.88014125 |
89 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.87899509 |
90 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.87770839 |
91 | FUS_26573619_Chip-Seq_HEK293_Human | 0.87695366 |
92 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.87424085 |
93 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.86985531 |
94 | PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.86584717 |
95 | TBL1_22424771_ChIP-Seq_293T_Human | 0.85649240 |
96 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.84666737 |
97 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.84095145 |
98 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.81369477 |
99 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.81165834 |
100 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80124569 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 6.32745324 |
2 | MP0004272_abnormal_basement_membrane | 4.55998531 |
3 | MP0003950_abnormal_plasma_membrane | 4.29886369 |
4 | MP0005503_abnormal_tendon_morphology | 3.67586590 |
5 | MP0005275_abnormal_skin_tensile | 3.51951181 |
6 | MP0005670_abnormal_white_adipose | 3.26524844 |
7 | MP0006054_spinal_hemorrhage | 2.99913793 |
8 | MP0003705_abnormal_hypodermis_morpholog | 2.86230542 |
9 | MP0001958_emphysema | 2.61754044 |
10 | MP0010386_abnormal_urinary_bladder | 2.49631868 |
11 | MP0003279_aneurysm | 2.16250449 |
12 | MP0010368_abnormal_lymphatic_system | 2.10861671 |
13 | MP0003186_abnormal_redox_activity | 2.07268607 |
14 | MP0005257_abnormal_intraocular_pressure | 1.95258464 |
15 | MP0000003_abnormal_adipose_tissue | 1.91954319 |
16 | MP0003941_abnormal_skin_development | 1.91193806 |
17 | MP0001542_abnormal_bone_strength | 1.88807364 |
18 | MP0005379_endocrine/exocrine_gland_phen | 1.86712683 |
19 | MP0005375_adipose_tissue_phenotype | 1.81574498 |
20 | MP0005084_abnormal_gallbladder_morpholo | 1.80254590 |
21 | MP0000749_muscle_degeneration | 1.80076509 |
22 | MP0002060_abnormal_skin_morphology | 1.75692195 |
23 | MP0005023_abnormal_wound_healing | 1.67700675 |
24 | MP0003195_calcinosis | 1.66399940 |
25 | MP0005666_abnormal_adipose_tissue | 1.66136399 |
26 | MP0003011_delayed_dark_adaptation | 1.59941399 |
27 | MP0002295_abnormal_pulmonary_circulatio | 1.58119590 |
28 | MP0005595_abnormal_vascular_smooth | 1.57327601 |
29 | MP0002971_abnormal_brown_adipose | 1.56243311 |
30 | MP0005164_abnormal_response_to | 1.55290433 |
31 | MP0009780_abnormal_chondrocyte_physiolo | 1.53696881 |
32 | MP0003566_abnormal_cell_adhesion | 1.52295065 |
33 | MP0005508_abnormal_skeleton_morphology | 1.44792311 |
34 | MP0009250_abnormal_appendicular_skeleto | 1.43139373 |
35 | MP0001879_abnormal_lymphatic_vessel | 1.40006123 |
36 | MP0010678_abnormal_skin_adnexa | 1.38895000 |
37 | MP0002108_abnormal_muscle_morphology | 1.32887735 |
38 | MP0000343_altered_response_to | 1.29382673 |
39 | MP0004883_abnormal_blood_vessel | 1.25282365 |
40 | MP0009697_abnormal_copulation | 1.24334895 |
41 | MP0001299_abnormal_eye_distance/ | 1.23714065 |
42 | MP0005623_abnormal_meninges_morphology | 1.21753154 |
43 | MP0000762_abnormal_tongue_morphology | 1.21482384 |
44 | MP0002970_abnormal_white_adipose | 1.21032468 |
45 | MP0002896_abnormal_bone_mineralization | 1.17024908 |
46 | MP0003828_pulmonary_edema | 1.14358589 |
47 | MP0003091_abnormal_cell_migration | 1.13779824 |
48 | MP0000647_abnormal_sebaceous_gland | 1.13119982 |
49 | MP0000767_abnormal_smooth_muscle | 1.11774153 |
50 | MP0009384_cardiac_valve_regurgitation | 1.10111152 |
51 | MP0004185_abnormal_adipocyte_glucose | 1.09032981 |
52 | MP0001243_abnormal_dermal_layer | 1.08642902 |
53 | MP0002796_impaired_skin_barrier | 1.07116281 |
54 | MP0010030_abnormal_orbit_morphology | 1.06638303 |
55 | MP0009115_abnormal_fat_cell | 1.03511701 |
56 | MP0000751_myopathy | 1.03246894 |
57 | MP0003252_abnormal_bile_duct | 1.03055834 |
58 | MP0000750_abnormal_muscle_regeneration | 1.02987363 |
59 | MP0005197_abnormal_uvea_morphology | 1.02555228 |
60 | MP0005165_increased_susceptibility_to | 0.99986414 |
61 | MP0009053_abnormal_anal_canal | 0.97714422 |
62 | MP0003959_abnormal_lean_body | 0.97379505 |
63 | MP0003191_abnormal_cellular_cholesterol | 0.97014492 |
64 | MP0001915_intracranial_hemorrhage | 0.93036336 |
65 | MP0001727_abnormal_embryo_implantation | 0.90433021 |
66 | MP0005193_abnormal_anterior_eye | 0.89685857 |
67 | MP0010771_integument_phenotype | 0.88655011 |
68 | MP0006138_congestive_heart_failure | 0.88423087 |
69 | MP0000759_abnormal_skeletal_muscle | 0.87095683 |
70 | MP0000428_abnormal_craniofacial_morphol | 0.84387430 |
71 | MP0001661_extended_life_span | 0.83926385 |
72 | MP0001881_abnormal_mammary_gland | 0.83207231 |
73 | MP0000163_abnormal_cartilage_morphology | 0.81102879 |
74 | MP0000013_abnormal_adipose_tissue | 0.81101580 |
75 | MP0005385_cardiovascular_system_phenoty | 0.80610147 |
76 | MP0001544_abnormal_cardiovascular_syste | 0.80610147 |
77 | MP0001851_eye_inflammation | 0.78258193 |
78 | MP0003868_abnormal_feces_composition | 0.77269001 |
79 | MP0005452_abnormal_adipose_tissue | 0.76741502 |
80 | MP0005332_abnormal_amino_acid | 0.76362413 |
81 | MP0004130_abnormal_muscle_cell | 0.75279859 |
82 | MP0002282_abnormal_trachea_morphology | 0.75256708 |
83 | MP0004233_abnormal_muscle_weight | 0.74273343 |
84 | MP0002972_abnormal_cardiac_muscle | 0.72264546 |
85 | MP0010329_abnormal_lipoprotein_level | 0.70859744 |
86 | MP0000534_abnormal_ureter_morphology | 0.68874264 |
87 | MP0002128_abnormal_blood_circulation | 0.68151896 |
88 | MP0002234_abnormal_pharynx_morphology | 0.67965638 |
89 | MP0000747_muscle_weakness | 0.67182458 |
90 | MP0004084_abnormal_cardiac_muscle | 0.66269832 |
91 | MP0010352_gastrointestinal_tract_polyps | 0.65417877 |
92 | MP0002876_abnormal_thyroid_physiology | 0.63182005 |
93 | MP0000230_abnormal_systemic_arterial | 0.62931407 |
94 | MP0001270_distended_abdomen | 0.62253124 |
95 | MP0005620_abnormal_muscle_contractility | 0.61530076 |
96 | MP0000249_abnormal_blood_vessel | 0.59771876 |
97 | MP0002168_other_aberrant_phenotype | 0.59555323 |
98 | MP0002269_muscular_atrophy | 0.59520612 |
99 | MP0002115_abnormal_skeleton_extremities | 0.59492773 |
100 | MP0005334_abnormal_fat_pad | 0.59442093 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protrusio acetabuli (HP:0003179) | 6.46848989 |
2 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 5.72594043 |
3 | Osteolytic defects of the hand bones (HP:0009699) | 5.72594043 |
4 | Premature rupture of membranes (HP:0001788) | 5.56116174 |
5 | Aortic aneurysm (HP:0004942) | 5.26722546 |
6 | Vascular tortuosity (HP:0004948) | 5.01722803 |
7 | Wormian bones (HP:0002645) | 4.64764609 |
8 | Aortic dissection (HP:0002647) | 4.63762698 |
9 | Autoamputation (HP:0001218) | 4.37989058 |
10 | Vertebral compression fractures (HP:0002953) | 3.99645183 |
11 | Soft skin (HP:0000977) | 3.94556284 |
12 | Arterial tortuosity (HP:0005116) | 3.90524844 |
13 | Follicular hyperkeratosis (HP:0007502) | 3.87093303 |
14 | Spondylolisthesis (HP:0003302) | 3.56655251 |
15 | Ankle contracture (HP:0006466) | 3.19688327 |
16 | Hyporeflexia of lower limbs (HP:0002600) | 3.11006317 |
17 | Spinal rigidity (HP:0003306) | 2.98755600 |
18 | 3-Methylglutaconic aciduria (HP:0003535) | 2.94558269 |
19 | Increased variability in muscle fiber diameter (HP:0003557) | 2.93769487 |
20 | Abnormality of dentin (HP:0010299) | 2.90888834 |
21 | Glucose intolerance (HP:0000833) | 2.84418104 |
22 | Renal Fanconi syndrome (HP:0001994) | 2.80666610 |
23 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.78525370 |
24 | Dilatation of the ascending aorta (HP:0005111) | 2.67954200 |
25 | Atrophic scars (HP:0001075) | 2.67320186 |
26 | Type 1 muscle fiber predominance (HP:0003803) | 2.63432081 |
27 | Muscle fiber splitting (HP:0003555) | 2.63192165 |
28 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.59151005 |
29 | Metaphyseal dysplasia (HP:0100255) | 2.57305254 |
30 | Cervical subluxation (HP:0003308) | 2.49283457 |
31 | Hydroxyprolinuria (HP:0003080) | 2.48853507 |
32 | Abnormality of proline metabolism (HP:0010907) | 2.48853507 |
33 | Slender build (HP:0001533) | 2.46886289 |
34 | Acanthosis nigricans (HP:0000956) | 2.45679113 |
35 | Blue sclerae (HP:0000592) | 2.40812231 |
36 | Ectopia lentis (HP:0001083) | 2.38143595 |
37 | Cardiovascular calcification (HP:0011915) | 2.37746379 |
38 | Microglossia (HP:0000171) | 2.37053173 |
39 | Acute necrotizing encephalopathy (HP:0006965) | 2.30054267 |
40 | Fragile skin (HP:0001030) | 2.27054934 |
41 | Mitral regurgitation (HP:0001653) | 2.22067964 |
42 | Bladder diverticulum (HP:0000015) | 2.21564400 |
43 | Absent frontal sinuses (HP:0002688) | 2.18255375 |
44 | Lipoatrophy (HP:0100578) | 2.17828323 |
45 | Neonatal short-limb short stature (HP:0008921) | 2.16459555 |
46 | Neck muscle weakness (HP:0000467) | 2.16257275 |
47 | Broad metatarsal (HP:0001783) | 2.13662907 |
48 | Delayed cranial suture closure (HP:0000270) | 2.12757889 |
49 | Acute encephalopathy (HP:0006846) | 2.09670176 |
50 | Tetraparesis (HP:0002273) | 2.09294483 |
51 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.08097494 |
52 | Nuclear cataract (HP:0100018) | 2.07017623 |
53 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.06614776 |
54 | Abnormality of placental membranes (HP:0011409) | 2.05668865 |
55 | Amniotic constriction ring (HP:0009775) | 2.05668865 |
56 | Biconcave vertebral bodies (HP:0004586) | 2.04833386 |
57 | Mitochondrial inheritance (HP:0001427) | 2.03375163 |
58 | Exertional dyspnea (HP:0002875) | 2.02825463 |
59 | Progressive macrocephaly (HP:0004481) | 2.01740888 |
60 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.99184832 |
61 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.97405197 |
62 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.96286010 |
63 | Mitral stenosis (HP:0001718) | 1.94721094 |
64 | Joint laxity (HP:0001388) | 1.94466960 |
65 | Mitral valve prolapse (HP:0001634) | 1.93522876 |
66 | Knee flexion contracture (HP:0006380) | 1.92776248 |
67 | Increased hepatocellular lipid droplets (HP:0006565) | 1.92216658 |
68 | Patent foramen ovale (HP:0001655) | 1.89884211 |
69 | Delayed gross motor development (HP:0002194) | 1.84839886 |
70 | Aplasia of the musculature (HP:0100854) | 1.84770006 |
71 | Hypertriglyceridemia (HP:0002155) | 1.84270968 |
72 | Aortic regurgitation (HP:0001659) | 1.83994864 |
73 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.82198112 |
74 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.82198112 |
75 | Single umbilical artery (HP:0001195) | 1.82198112 |
76 | Abnormality of the anterior chamber (HP:0000593) | 1.81620747 |
77 | Abnormality of the acetabulum (HP:0003170) | 1.79900049 |
78 | Elbow flexion contracture (HP:0002987) | 1.79478458 |
79 | Hepatocellular necrosis (HP:0001404) | 1.78666455 |
80 | Abnormal glucose tolerance (HP:0001952) | 1.77098909 |
81 | Bone cyst (HP:0012062) | 1.76769816 |
82 | Abnormality of alanine metabolism (HP:0010916) | 1.75273275 |
83 | Hyperalaninemia (HP:0003348) | 1.75273275 |
84 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.75273275 |
85 | Generalized amyotrophy (HP:0003700) | 1.73670484 |
86 | Hyperextensible skin (HP:0000974) | 1.73638398 |
87 | Cerebral edema (HP:0002181) | 1.70523546 |
88 | Oligomenorrhea (HP:0000876) | 1.70021980 |
89 | Genu recurvatum (HP:0002816) | 1.69664476 |
90 | Redundant skin (HP:0001582) | 1.68839894 |
91 | Increased muscle lipid content (HP:0009058) | 1.68570493 |
92 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.68265557 |
93 | Vascular calcification (HP:0004934) | 1.67864201 |
94 | Overgrowth (HP:0001548) | 1.67805273 |
95 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.65971132 |
96 | Nemaline bodies (HP:0003798) | 1.64276901 |
97 | Abnormality of renal resorption (HP:0011038) | 1.63965941 |
98 | Abnormal delivery (HP:0001787) | 1.63494733 |
99 | Abnormality of the umbilical cord (HP:0010881) | 1.63364970 |
100 | Shallow orbits (HP:0000586) | 1.63229605 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BRSK2 | 6.27286827 |
2 | MAP3K12 | 5.56992056 |
3 | MYLK | 5.06269647 |
4 | WEE1 | 3.76666233 |
5 | PBK | 2.89993748 |
6 | BRSK1 | 2.66745266 |
7 | NEK9 | 2.33276853 |
8 | PAK4 | 2.28500525 |
9 | EPHB2 | 2.15444424 |
10 | DDR2 | 2.09503733 |
11 | MST4 | 1.92088099 |
12 | TGFBR2 | 1.87865898 |
13 | TESK1 | 1.84157975 |
14 | EIF2AK1 | 1.80339130 |
15 | BCR | 1.68155847 |
16 | LATS2 | 1.67853364 |
17 | LIMK1 | 1.54545217 |
18 | ABL2 | 1.42732434 |
19 | ILK | 1.39924580 |
20 | VRK2 | 1.39733010 |
21 | PTK2 | 1.32446884 |
22 | ARAF | 1.31666271 |
23 | MST1R | 1.31118597 |
24 | TRIM28 | 1.27178269 |
25 | EIF2AK3 | 1.23130098 |
26 | PAK2 | 1.20176689 |
27 | PDGFRA | 1.19683781 |
28 | MAP3K13 | 1.18423517 |
29 | NME2 | 1.18363185 |
30 | ERBB4 | 1.17504152 |
31 | CASK | 1.15520552 |
32 | STK16 | 1.14060334 |
33 | DAPK3 | 1.12514007 |
34 | BMPR1B | 1.12149774 |
35 | NEK1 | 1.09930183 |
36 | MOS | 1.08643033 |
37 | CDK8 | 1.04404636 |
38 | PKN1 | 0.98501121 |
39 | TIE1 | 0.98052117 |
40 | GRK5 | 0.96996477 |
41 | FLT3 | 0.96906800 |
42 | STK38L | 0.92032694 |
43 | MET | 0.89909052 |
44 | LATS1 | 0.85815715 |
45 | TAF1 | 0.85529979 |
46 | ADRBK1 | 0.82572494 |
47 | NUAK1 | 0.79376702 |
48 | ROCK1 | 0.79330445 |
49 | BUB1 | 0.77459180 |
50 | STK38 | 0.76570980 |
51 | TRPM7 | 0.71209386 |
52 | MUSK | 0.69813389 |
53 | EPHA2 | 0.69679288 |
54 | GSK3A | 0.67499812 |
55 | PRKCE | 0.67262872 |
56 | DAPK1 | 0.66496918 |
57 | EIF2AK2 | 0.65732608 |
58 | SMG1 | 0.64740021 |
59 | SIK3 | 0.63380663 |
60 | PRKD2 | 0.62336593 |
61 | MAP2K1 | 0.61622166 |
62 | ROCK2 | 0.58748632 |
63 | PINK1 | 0.58517517 |
64 | ERBB3 | 0.57472845 |
65 | PIM2 | 0.56930625 |
66 | CAMK2G | 0.56186007 |
67 | SIK1 | 0.54167278 |
68 | MKNK2 | 0.50940286 |
69 | FER | 0.49576180 |
70 | PIK3CG | 0.48771423 |
71 | PLK2 | 0.47418579 |
72 | NTRK1 | 0.46864827 |
73 | PDGFRB | 0.46072308 |
74 | AURKA | 0.45896620 |
75 | GRK1 | 0.45563002 |
76 | CDK9 | 0.43910055 |
77 | PRKG1 | 0.40742501 |
78 | PAK1 | 0.40411762 |
79 | PRKAA2 | 0.39875792 |
80 | CDK4 | 0.37568140 |
81 | PNCK | 0.37178465 |
82 | TAOK2 | 0.36497982 |
83 | MAPK7 | 0.35632263 |
84 | MAP3K3 | 0.34265774 |
85 | NME1 | 0.33127011 |
86 | PLK3 | 0.32253276 |
87 | GRK7 | 0.31747386 |
88 | PLK1 | 0.30989339 |
89 | TNIK | 0.28966557 |
90 | CAMK2D | 0.28308363 |
91 | FGFR1 | 0.28268224 |
92 | TTK | 0.28258619 |
93 | MAPKAPK2 | 0.28229521 |
94 | ABL1 | 0.27612508 |
95 | SCYL2 | 0.26784911 |
96 | STK3 | 0.25879422 |
97 | PTK2B | 0.24244805 |
98 | CAMK2B | 0.24218835 |
99 | PRKD1 | 0.22501881 |
100 | ADRBK2 | 0.21350999 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 3.16926019 |
2 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.16132457 |
3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.00689088 |
4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.56436067 |
5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.55048048 |
6 | Protein export_Homo sapiens_hsa03060 | 2.54084832 |
7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.26180791 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.25851632 |
9 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.02582941 |
10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.01291811 |
11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.91583128 |
12 | Parkinsons disease_Homo sapiens_hsa05012 | 1.89663176 |
13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.89156401 |
14 | Focal adhesion_Homo sapiens_hsa04510 | 1.82567445 |
15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.66702101 |
16 | Sulfur relay system_Homo sapiens_hsa04122 | 1.66223525 |
17 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.64048867 |
18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.58691040 |
19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.54058349 |
20 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.54001314 |
21 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.53750533 |
22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.51924619 |
23 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.45348261 |
24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.42075750 |
25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.41626317 |
26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.41332699 |
27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.39312392 |
28 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.38910001 |
29 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.37410189 |
30 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36732722 |
31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.30333212 |
32 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.29955229 |
33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.29010403 |
34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24074606 |
35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.22280712 |
36 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.12695099 |
37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.11003878 |
38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.10424862 |
39 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.10287496 |
40 | Circadian rhythm_Homo sapiens_hsa04710 | 1.05220264 |
41 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.04029537 |
42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00017039 |
43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.99097314 |
44 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.95948484 |
45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95146081 |
46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94347964 |
47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.94310828 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92544287 |
49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.92252685 |
50 | Melanoma_Homo sapiens_hsa05218 | 0.90137803 |
51 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.88980166 |
52 | Adherens junction_Homo sapiens_hsa04520 | 0.86722808 |
53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.85930498 |
54 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.85522665 |
55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84264839 |
56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84143156 |
57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.83715332 |
58 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.80361831 |
59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.80299799 |
60 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80153812 |
61 | RNA polymerase_Homo sapiens_hsa03020 | 0.78036059 |
62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78002977 |
63 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77103377 |
64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72377775 |
65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70432769 |
66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65246482 |
67 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.65089538 |
68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62913693 |
69 | Malaria_Homo sapiens_hsa05144 | 0.62390047 |
70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62136772 |
71 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61679748 |
72 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60856680 |
73 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.60200888 |
74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59733575 |
75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58930453 |
76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57810898 |
77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55189126 |
78 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54882569 |
79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54809749 |
80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54346908 |
81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51304257 |
82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50574472 |
83 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48870744 |
84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48788926 |
85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47971969 |
86 | Ribosome_Homo sapiens_hsa03010 | 0.46304761 |
87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45696445 |
88 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43959173 |
89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43781040 |
90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41931191 |
91 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41143672 |
92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40395847 |
93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39464015 |
94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38468376 |
95 | Amoebiasis_Homo sapiens_hsa05146 | 0.37206552 |
96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36875564 |
97 | Tight junction_Homo sapiens_hsa04530 | 0.36366915 |
98 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.36236629 |
99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35541186 |
100 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.35192869 |